Impact of Rifaximin Therapy on Intestinal Byproducts in Chronic Kidney Disease
Phase of Trial: Phase IV
Latest Information Update: 02 May 2017
At a glance
- Drugs Rifaximin (Primary)
- Indications Kidney disorders
- Focus Therapeutic Use
- 26 Apr 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 26 Apr 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Feb 2018.
- 24 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.